BEIJING, Feb. 17, 2015 /PRNewswire/ -- China Biologic
Products, Inc. (NASDAQ: CBPO)
("China Biologic" or the "Company"), a leading fully
integrated plasma-based biopharmaceutical company in China, today announced that the Company plans
to release fourth quarter and fiscal year 2014 financial results
on, March 4, 2015, after the market
closes.
The Company's management will hold a conference call at
7:30a.m. ET on Thursday, March 5, 2015, which is 8:30p.m., Beijing Time on, March 5, 2015, to discuss fourth quarter and
fiscal year 2014 results. Listeners may access the call by
dialing:
US:
|
1 888 346 8982
|
International:
|
1 412 902 4272
|
Hong Kong:
|
800 905 945
|
Mainland
China:
|
400 120 6113
|
A telephone replay will be available one hour after the
conclusion of the conference call through March 12, 2015. The dial-in details are:
US:
|
1 877 344 7529
|
International:
|
1 412 317 0088
|
Passcode:
|
10060992
|
A live and archived webcast of the conference call will be
available through the Company's investor relations website at
http://chinabiologic.investorroom.com.
About China Biologic Products, Inc.
China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully
integrated plasma-based biopharmaceutical company in China. The Company's products are used as
critical therapies during medical emergencies and for the
prevention and treatment of life-threatening diseases and
immune-deficiency related diseases. China Biologic is headquartered
in Beijing and manufactures over
20 different dosages of plasma-based products through its indirect
majority-owned subsidiaries, Shandong Taibang Biological Products
Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. The
Company also has an equity investment in Xi'an Huitian Blood
Products Co., Ltd. The Company sells its products to hospitals and
other healthcare facilities in China. For additional information, please see
the Company's website www.chinabiologic.com.
Contact:
China Biologic Products, Inc.
Mr. Ming Yin
Senior Vice President
Phone: +86-10-6598-3099
Email: ir@chinabiologic.com
ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
E-mail: william.zima@icrinc.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/china-biologic-products-to-report-fourth-quarter-and-fiscal-year-2014-financial-results-300036311.html
SOURCE China Biologic Products, Inc.